Blog
Opioid Crisis and drugmaker reporting
By Pharma & Healthcare Dimensions |
It’s clear the opioid crisis is real. It’s not as clear, though, what kind of obligation this crisis might trigger ...
Read More Rx Price Reforms: PART III: Pricing Formulas, Consistent with Reform
By Pharma & Healthcare Dimensions |
Ultimately, controlling drug pricing is a shell game. Fixing national drug spend promotes a stronger economy (GDP). Negotiating lower Medicare ...
Read More Rx Price Reforms: PART II: Whom are We Trying to Help, Anyhow?
By Pharma & Healthcare Dimensions |
I recently staked my claim that the Class of 2019 drug price reforms don’t include much new, effective, or even ...
Read More Rx Price Reforms: PART I: We Already KNOW what DOESN’T Work
By Pharma & Healthcare Dimensions |
When it comes to controlling costs for prescription drugs, everybody wants to get into the act this year. With so ...
Read More - « Previous
- 1
- 2
- 3